⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
Contact Levi & Korsinsky by October 5, 2026 to Join Class Action Against ARS Pharmaceuticals, Inc. (SPRY)
accessnewswire.com
SPRY
Pomerantz LLP Updates Investors on Legal Action Brought Against ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Pentair plc (PNR), Datavault AI Inc. (DVLT), and ARS Pharmaceuticals, Inc. (SPRY) Announced by Holzer & Holzer, LLC
globenewswire.com
PNR
DVLT
SPRY
מועד אחרון לתביעה ייצוגית נגד ARS PHARMACEUTICALS: רוזן, יועץ למשקיעים מהימן, קורא למשקיעי ARS Pharmaceuticals, Inc. לשכור ייצוג משפטי לקראת מועד אחרון חשוב בתביעה הייצוגית בניירות הערך – SPRY
globenewswire.com
SPRY
Investors Urged to Contact Levi & Korsinsky For Information Before October 5, 2026 - ARS Pharmaceuticals, Inc. (SPRY)
accessnewswire.com
SPRY
Recover Investment Losses: Class Action Initiated Against ARS Pharmaceuticals, Inc. (SPRY)
accessnewswire.com
SPRY
ARS PHARMACEUTICALS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY
accessnewswire.com
SPRY
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – SPRY
globenewswire.com
SPRY
Levi & Korsinsky Notifies ARS Pharmaceuticals, Inc. (SPRY) Shareholders of Class Action Lawsuit and October 5, 2026 Deadline
accessnewswire.com
SPRY
ARS PHARMACEUTICALS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SPRY
globenewswire.com
SPRY